Related Experiment Video
Updated: Jun 13, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
ARumenamides as Multitarget Ion Channel Modulators: Insights from Fenestration-Focused Docking, ADMET Profiling, and
Mena Abdelsayed1, Yassir Boulaamane2
1Lankenau Institute for Medical Research, Philadelphia, PA 19096, USA.
Novel ARumenamides show potential as multitarget ion channel modulators for treating cardiac and neuromuscular disorders. Computational studies reveal specific binding sites and favorable safety profiles for developing new polypharmacological therapies.
Area of Science:
- Pharmacology
- Computational Chemistry
- Structural Biology
Background:
- Voltage-gated ion channels are crucial for muscle and nerve function.
- Dysfunction leads to channelopathies like arrhythmias and neuromuscular disorders.
- Polypharmacology, targeting multiple ion channel subtypes, offers therapeutic potential.
Purpose of the Study:
- To investigate the multitarget binding mechanisms of ARumenamide derivatives.
- To evaluate their potential as polypharmacological therapeutics for ion channelopathies.
- To establish a structure-dynamics framework for rational ARumenamide design.
Main Methods:
- Structure-based computational workflow including molecular docking.
- In silico ADMET profiling for safety and absorption assessment.
- Long-timescale molecular dynamics simulations (250 ns) on 15 ion channel structures.
Main Results:
- ARumenamides demonstrated broad multitarget binding across sodium, calcium, and potassium channels.
- Most derivatives showed favorable ADMET profiles, with some exceptions.
- Molecular dynamics revealed site-specific binding and dynamic retention for prioritized compounds (AR-310, AR-769, AR-946).
Conclusions:
- ARumenamides can act as multitarget ion channel modulators.
- Fenestration-focused binding offers sustained ligand engagement without pore occlusion.
- This study provides a framework for designing novel polypharmacological therapeutics for channelopathies.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated Ion Channels
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Patch Clamp
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
